-
-
-
-
-
-
-
Galena Biopharma Appoints Mary Ann Gray, Ph.D., to Its Board of Directors
-
-
-
-
-
-
-
Galena Biopharma Announces Closing of Over-Allotment Option, Increasing Total Gross Proceeds to $43.7 Million
-
-
-
-
-
-
-
Galena Biopharma (GALE) Plans Common Stock Offering
-
-
-
-
-
-
-
Notable Analyst Rating Changes 05/22: (BMY) (CREE) (TEX) Upgraded; (IGTE) (CCL) (NCT) Downgraded
-
-
27,146 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All